Viewing Study NCT07087405


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2025-12-26 @ 2:09 AM
Study NCT ID: NCT07087405
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-28
First Post: 2025-07-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Striae Distensae Treatment Using Deep Skin Abrasion
Sponsor: Boston Children's Hospital
Organization:

Study Overview

Official Title: Stretch Mark Treatment Using Subcutaneous Skin Abrasion
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to learn if a device works to treat striae distensae. It will also learn about the safety of the device. The main questions it aims to answer are:

1. Does the device improve the appearance of striae distensae?
2. Does the device cause any problems when treating striae distensae? Researchers will compare the appearance of striae distensae before and after treatment with the device.

Participants will:

1. Undergo treatment with the device in the clinic
2. Visit the clinic 1 week, 3 months, and 1 year for checkups and tests
Detailed Description: Participants will have the area of striae distensae anesthetized with local anesthetic. A biopsy will be performed and a device will be placed underneath the skin that will abrade the skin. Three months later another biopsy will be performed, photographs will be taken, and participants will fill out surveys to determine the effectiveness of the device to improve the appearance of the striae distensae.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: